1Jacobs 1,Oram D,Fairbanks J,et al.A risk of malignancy index incorporating CA125,ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer[J].Br J Obstet Gynecol,1990,97(10):922-29.
2Nolen B,Velikokhatnays L,Marrangoni A,et al.Serum hiomarker panels for the discrimination of benign from malignant cases in patients with an adnexal maaalJ].Gynecol Oncol,2010,117(3):440-445.
4Andersen ES,Knudsen A,Rix P,et al.Risk of malignant index in the preoperative evaluation of patients with adnexal masses[J].Gynecot Oncol,2003,90(1):109-112.
5Van den Akker PA,Aalders AL,Snijders MP,et al.Evaluation of the risk of malignancy index in daily clinical management of adnexal mmses[J].Gynecol Oncol,2010,116(3):384-388.
3Tingulstad S,Hagen B,Skjeldestad FE,et al.Evaluation of a risk of malignance index based on serum CA125,ultrasound findings and menopausal status in the preoperative diagnosis of pelvic masses.Br J Obstet Gynecol,1996,103:826-831.
4Menon U,Jacobs IJ.Recent developments in ovantian cancer screening.Curr Opin Obstet Gynecol,2000,12:39-42.
